814. Deputy Seán Ó Fearghaíl asked the Minister for Health further to Parliamentary Question No. 177 of 18 May 2022, when voretigene neparvovec luxturna will be added to the reimbursement list in line with the Health Act 2013 and the national framework agreed with the pharmaceutical industry under which a company must submit an application to the HSE to have a new medicine approved; and if she will make a statement on the matter. [25372/25]

Summary

814. Deputy Seán Ó Fearghaíl asked the Minister for Health further to Parliamentary Question No. 177 of 18 May 2022, when voretigene neparvovec luxturna will be added to the reimbursement list in line with the Health Act 2013 and the national framework agreed with the pharmaceutical industry under which a company must submit an application to the HSE to have a new medicine approved; and if she will make a statement on the matter. [25372/25]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products

  xml · EN · 20 May 2025

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.